Global X Genomics & Biotechnology ETF Rating $38.08 +0.61 (+1.63%) As of 12:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.71Holdings in GNOM have an aggregate rating of Moderate Buy based on 390 analyst ratings issued in the past year covering 23 companies (79.6% of the portfolio).GNOM Aggregate Price Target$37.92-0.41% DownsideHigh Prediction$37.92Average Prediction$37.92Low Prediction$37.92Holdings in GNOM have an aggregate price target of $37.92 and a range of $37.92 to $37.92 covering 23 companies (79.6% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.78%ALNYAlnylam Pharmaceuticals$459.94+1.2%3.7613 of 5 stars2.86$439.58 -4.4%285.57%CRSPCRISPR Therapeutics$61.51+1.2%3.237 of 5 stars2.50$71.50 16.2%18Analyst Forecast4.81%ILMNIllumina$95.56-3.8%4.8211 of 5 stars2.21$123.06 28.8%19Positive News4.74%RNAAvidity Biosciences$43.92+3.8%2.0717 of 5 stars3.05$68.32 55.5%19Analyst Forecast4.55%GHGuardant Health$57.95-3.0%3.8021 of 5 stars3.05$59.00 1.8%19Analyst ForecastGap Up4.29%NTRANatera$167.53-3.1%3.4996 of 5 stars3.00$192.88 15.1%19Positive NewsAnalyst Forecast3.96%ARWRArrowhead Pharmaceuticals$33.22+2.2%4.1388 of 5 stars3.00$43.14 29.9%83.90%QGENQIAGEN$45.07-1.2%4.3282 of 5 stars2.27$49.69 10.2%113.79%WGSGeneDx$115.18-5.2%2.174 of 5 stars2.75$104.13 -9.6%83.73%TECHBio-Techne$51.47-2.7%4.9837 of 5 stars2.77$70.42 36.8%133.65%LEGNLegend Biotech$32.84-0.3%3.1512 of 5 stars2.91$74.22 126.0%11Positive News3.42%MRNAModerna$25.70-0.4%4.4567 of 5 stars2.05$41.81 62.7%223.19%BMRNBioMarin Pharmaceutical$53.53+0.2%4.9623 of 5 stars2.64$92.60 73.0%22Positive News3.10%BNTXBioNTech$99.26+1.0%2.6818 of 5 stars2.79$134.56 35.6%14Analyst Forecast2.91%VCYTVeracyte$33.36-2.3%3.7834 of 5 stars2.70$40.90 22.6%10News CoveragePositive News2.85%VRTXVertex Pharmaceuticals$377.68-0.5%4.9106 of 5 stars2.57$496.05 31.3%28Positive NewsAnalyst Revision2.79%RAREUltragenyx Pharmaceutical$28.81+1.4%4.3879 of 5 stars2.92$81.50 182.9%12Positive News2.29%BEAMBeam Therapeutics$23.99+1.1%2.997 of 5 stars3.08$46.40 93.5%132.19%AAgilent Technologies$125.10-0.7%4.5092 of 5 stars2.50$140.08 12.0%12Positive NewsDividend Announcement1.92%GILDGilead Sciences$112.81-1.4%4.9313 of 5 stars2.89$117.17 3.9%28Positive News1.81%TWSTTwist Bioscience$26.99-2.4%3.7751 of 5 stars2.73$49.40 83.1%111.73%BMYBristol Myers Squibb$44.40-1.1%4.9276 of 5 stars2.24$56.38 27.0%21Positive NewsDividend Announcement1.66%LLYEli Lilly and Company$739.28-1.0%4.9978 of 5 stars2.67$939.61 27.1%24Trending News This page (NASDAQ:GNOM) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts